Immunogenetics of Multiple Sclerosis

Multiple sclerosis (MS) was one of the first conditions shown to be associated with HLA class II factors. Find the latest research on MS here, including HLA studies providing insights on the genetics of the susceptibility to MS.

January 17, 2022

T cells, α-synuclein and Parkinson disease.

Handbook of Clinical Neurology
Francesca GarrettiDavid Sulzer
January 15, 2022
Open Access

Modulation of Ryanodine Receptors Activity Alters the Course of Experimental Autoimmune Encephalomyelitis in Mice.

Frontiers in Physiology
Natalia C OsipchukAlla F Fomina
January 15, 2022

The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosis.

Irish Journal of Medical Science
Audrey ReynoldsNiall Conlon
January 14, 2022
Review

Genetics and functional genomics of multiple sclerosis.

Seminars in Immunopathology
Woori Kim, Nikolaos A Patsopoulos
January 14, 2022

Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Britta E JonesJane H Buckner
January 13, 2022

Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?

Clinical and Experimental Immunology
David BakerRuth Dobson
January 12, 2022
Preprint
Open Access

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis

MedRxiv : the Preprint Server for Health Sciences
Kathryn C. FitzgeraldE. M. Mowry
January 12, 2022
Open Access

T-Cell Response against Varicella Zoster Virus in Patients with Multiple Sclerosis during Relapse and Remission.

International Journal of Molecular Sciences
Miriam Pérez-SaldívarMartha Espinosa-Cantellano
January 10, 2022
Preprint
Open Access

Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study

MedRxiv : the Preprint Server for Health Sciences
I. KisterGregg J Silverman
January 5, 2022
Open Access

Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.

Journal of Translational Medicine
Renxi Wang
January 4, 2022
Review
Open Access

T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration.

Frontiers in Immunology
Lixiang Wang, Xin Wei
January 4, 2022
Open Access

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.

Frontiers in Immunology
Josefine RuderRoland Martin
December 31, 2021
Open Access

Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients - An In Vitro Study.

Frontiers in Immunology
Minodora DobreanuRodica Bălaşa
December 30, 2021
Preprint
Open Access

Biological Aging of CNS-Resident Cells Alters the Clinical Course and Immunopathology of Autoimmune Demyelinating Disease

BioRxiv : the Preprint Server for Biology
J. R. AtkinsonBenjamin M Segal

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/immunogenetics-of-multiple-sclerosis/9d5615cd-7a41-4d6a-bc9c-a8b979346b06